The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072016
Willimsky et al.

Figure S1 Additional representative PMLs in mice that recently developed anti-Tag antibodies but without macroscopically detectable tumors.

Figure S2 FoxP3 control staining of lymph nodes.

Figure S3 Mice with PMLs and tumors show accumulation of IgG/TGF-β1 double-positive cells in draining lymph nodes.

Figure S4 CD11b-positive splenocytes from LoxP-Tag and LoxP-Tag × Alb-Cre transgenic mice do not show significant phenotypical differences.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS